Back to Search Start Over

Supplementary Table 3 from High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib

Supplementary Table 3 from High BCR–ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib

Authors :
Francesco Di Raimondo
Andreas Hochhaus
Martin C. Müller
Livia Manzella
Bruno Martino
Stefano Molica
Fortunato Morabito
Maurizio Musso
Pamela Murgano
Carmela Tomaselli
Giuseppe Mineo
Alessandra Malato
Caterina Musolino
Stefana Stella Impera
Donato Mannina
Sergio Siragusa
Agostino Antolino
Michele Massimino
Stefano Forte
Alessandra Cupri
Stefania Stella
Fabio Stagno
Paolo Vigneri
Publication Year :
2023
Publisher :
American Association for Cancer Research (AACR), 2023.

Abstract

Supplementary Table 3. ROC curves correlating BCR-ABL/ABL levels at diagnosis with 8-year estimates of OS, TFS, FFS, EFS and Optimal Response

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....d7b2ae601363caf39ea8351ceb833045
Full Text :
https://doi.org/10.1158/1078-0432.22466627.v1